Showing results (791-800 of 828) with videos related to

Sort By:
Pageof 83
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 1, 1996
Proton dosimetry intercomparisonS Vatnitsky, J Siebers, D Miller, et al.
Journal of Biological Methods|March 24, 2020
An optimized procedure for isolation of rodent and human skeletal muscle sarcoplasmic and myofibrillar proteinsMichael D Roberts, Kaelin C Young, Carlton D Fox, et al.
Scientific Reports|July 26, 2018
Soy protein supplementation is not androgenic or estrogenic in college-aged men when combined with resistance exercise trainingCody T Haun, C Brooks Mobley, Christopher G Vann, et al.
Physical Review Letters|March 30, 2021
Role of Chiral Two-Body Currents in ^{6}Li Magnetic Properties in Light of a New Precision Measurement with the Relative Self-Absorption TechniqueU Friman-Gayer, C Romig, T Hüther, et al.
Scientific Reports|August 12, 2018
Author Correction: Soy protein supplementation is not androgenic or estrogenic in college-aged men when combined with resistance exercise trainingCody T Haun, C Brooks Mobley, Christopher G Vann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2016
A randomized adaptive phase II/III study of buparlisib, a pan-class I PI3K inhibitor, combined with paclitaxel for the treatment of HER2- advanced breast cancer (BELLE-4)M Martín, A Chan, L Dirix, et al.
Breast Cancer Research : BCR|August 31, 2023
Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2- advanced breast cancer receiving first-line ribociclib plus fulvestrantP Neven, P A Fasching, S Chia, et al.
Physical Review Letters|August 18, 2025
Deviations from the Porter-Thomas Distribution due to Nonstatistical γ Decay below the ^{150}Nd Neutron Separation ThresholdO Papst, J Isaak, V Werner, et al.
The Lancet. Oncology|January 5, 2016
TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trialElisabeth Quoix, Hervé Lena, Gyorgy Losonczy, et al.
Frontiers in Physiology|April 16, 2020
Skeletal Muscle Protein Composition Adaptations to 10 Weeks of High-Load Resistance Training in Previously-Trained MalesChristopher G Vann, Shelby C Osburn, Petey W Mumford, et al.
Pageof 83